Kojic acid underarm serum products are classified as cosmetics in most jurisdictions (US, EU, Canada) as long as they make only aesthetic claims (brightening, evening skin tone) and do not claim to treat, cure, or prevent a disease or condition. However, if your product claims a deodorant benefit (odor reduction or odor prevention), it shifts to over-the-counter drug classification in the US and requires either a deodorant active ingredient (like aluminum zirconium compounds) or formal FDA approval as a new drug. Regulatory requirements vary significantly by region, so understanding your target market's rules before formulation and manufacturing is essential.
In the United States, kojic acid serums positioned as brightening or skin-tone evening products are considered cosmetics under FDA jurisdiction and must comply with the Federal Food, Drug, and Cosmetic Act (FD&C Act). The US does not pre-approve cosmetic products, but cosmetics must be truthfully and non-deceptively labeled, contain only safe ingredients (kojic acid is listed as safe for leave-on cosmetics), and comply with Good Manufacturing Practices (GMP). Kojic acid itself is not restricted in the US, though it's sometimes used in over-the-counter topicals for melasma and hyperpigmentation. The key regulatory risk is over-claiming: if your label says "clinically proven to eliminate underarm darkening" or "treats hyperpigmentation," the FDA may reclassify your product as a drug and demand clinical evidence or approval. Conservative claim language like "helps reduce the appearance of darkening" or "promotes a more even skin tone" stays safely in cosmetics territory. If you include a separate deodorant benefit (odor prevention), you must add an FDA-approved deodorant active like aluminum zirconium triclocarban (1–15%), which necessitates drug labeling and manufacturing controls.
The FDA requires all cosmetics manufacturers to register their facilities with the Cosmetic Facility Registration system and to maintain substantiation for any claims made. For kojic acid brightness claims, substantiation can be ingredient data (published studies on kojic acid's tyrosinase inhibition), consumer perception testing (before-and-after photos or consumer panels showing perceived skin improvement), or clinical studies. You don't need published clinical trials, but you must have a reasonable basis for your claims. Kojic acid is well-researched in dermatology literature, so referencing published safety and efficacy data is straightforward. Your manufacturer or a third-party lab can conduct 4-week or 8-week consumer perception studies (30–50 volunteers) for $2,000–$5,000, which provides defensible claim support.
In the European Union, kojic acid undergoes stricter scrutiny. The EU restricts kojic acid in cosmetics to a maximum of 2% in leave-on products (your serum likely falls here), and it's classified as a potential skin sensitizer in high concentrations. EU Annex III (banned substances) does not list kojic acid, so it's permitted, but you must respect the 2% cap and include appropriate caution language on the label if it approaches that limit. The EU also prohibits bleaching or depigmenting claims (you cannot say your serum "lightens" or "whitens" skin in an absolute sense), so framing matters: "brightens" or "evens skin tone" is acceptable; "lightening" or "skin-bleaching" is not. All cosmetics sold in the EU must have a Safety Assessment Report prepared by a qualified cosmetic safety assessor, which your manufacturer should provide or facilitate. Kojic acid is listed as safe for cosmetic use in the EU, so the assessment is typically straightforward.
Canada's regulations through Health Canada are similar to the US but with some differences. Kojic acid is permitted in cosmetics, and there's no pre-market approval required, but cosmetics must be safe for intended use and labeled honestly. If your underarm serum is positioned as a deodorant, Health Canada classifies it as a Non-Prescription Drug and requires NPN (Natural Product Number) registration if it contains herbal or natural actives, or a DIN (Drug Identification Number) if it contains pharmaceutical actives. A pure brightening serum stays in cosmetics. Canada's labeling rules require bilingual (English-French) packaging for domestic sales, which adds label design complexity.
Japan permits kojic acid in cosmetics at up to 2% (similar to the EU), and it's well-established in Japanese beauty products for brightening. Japan's regulatory pathway for cosmetics is straightforward: no pre-approval, but ingredients must be on the approved list. Kojic acid is approved, and substantiation for brightening claims is less stringent than in the US or EU. However, if you plan to distribute into Japan, sourcing your kojic acid from a Japanese supplier often simplifies regulatory navigation.
Australia and New Zealand (via ASEAN guidelines) also permit kojic acid in cosmetics without restriction, though labeling and TGA (Therapeutic Goods Administration) compliance applies. In Australia, if you make claims related to skin lightening, it triggers scrutiny because of historical concerns around non-ethical skin-bleaching products. Framing your claim around "brightness" or "tone evening" (not "lightening") avoids regulatory pushback.
Key regulatory steps before launching: (1) Define your target markets clearly (US only, US + EU, global). (2) Finalize your claim language with your manufacturer or a regulatory consultant to ensure it stays within cosmetics classification and doesn't trigger drug reclassification. (3) Request substantiation documentation from your manufacturer (ingredient safety data, stability data, claim support if applicable). (4) If applicable, file facility registration with the FDA and notify Health Canada. (5) Ensure your label includes required elements (ingredient declaration, precautions, manufacturer/distributor info, proper language translations). (6) Conduct a batch stability test (shelf-life validation) before commercial launch. (7) Maintain records of your formula, safety assessment (for EU), and any clinical or consumer testing data.
Common mistakes first-timers make: overstating brightening claims (saying it "eliminates" darkening instead of "helps reduce the appearance"), forgetting to account for regional claim restrictions (especially the EU's 2% kojic acid cap and prohibition on bleaching language), and failing to budget for claim substantiation or bilingual labeling if exporting. Some manufacturers will draft labels for you, but they won't guarantee regulatory compliance across all jurisdictions—that's your responsibility as the brand owner. On the AJ Cosmo Labs platform, when you connect with vetted manufacturers, you can ask them directly about regulatory experience in your target markets and whether they'll support claim substantiation and label review as part of your development fee.
Ingredients in this answer: Kojic Acid
Read the full guide on Private Label Kojic Acid Underarm Serum Manufacturer Low MOQ →